The effect of dietary intervention on serum lipid levels in type 2 diabetes mellitus
- PMID: 12643187
- DOI: 10.1007/s11892-002-0097-z
The effect of dietary intervention on serum lipid levels in type 2 diabetes mellitus
Abstract
Dietary therapy is the cornerstone of lipid management in patients with type 2 diabetes mellitus. The key strategies are the reduction of intake of saturated fat, trans unsaturated fat and cholesterol, and the reduction of energy intake to promote weight loss. This approach will produce significant improvements in the serum levels of low-density lipoprotein (LDL) cholesterol, triglycerides, and high-density lipoprotein (HDL) cholesterol. According to both the American Diabetes Association and the National Cholesterol Education Program (NCEP), the primary target of therapy is the serum LDL cholesterol level, with the secondary targets being non-HDL cholesterol, triglycerides, and HDL cholesterol. The recently updated guidelines of the NCEP place new emphasis on increasing soluble fiber intake to 10 to 25 g/d and adding foods fortified with plant stanols/sterols (2 g/d) as options to enhance the LDL cholesterol-lowering effect of diet.
Similar articles
-
High-soluble-fiber foods in conjunction with a telephone-based, personalized behavior change support service result in favorable changes in lipids and lifestyles after 7 weeks.J Am Diet Assoc. 2002 Apr;102(4):503-10. doi: 10.1016/s0002-8223(02)90116-1. J Am Diet Assoc. 2002. PMID: 11985406 Clinical Trial.
-
Effect of a low-fat diet enriched with oleic acid on postprandial lipemia in patients with type 2 diabetes mellitus.Lipids. 2001 Jan;36(1):1-6. doi: 10.1007/s11745-001-0660-5. Lipids. 2001. PMID: 11214722 Clinical Trial.
-
Biological variation of serum lipids and lipoproteins in patients with clinically well controlled non insulin dependent diabetes mellitus.Endocr J. 1996 Jun;43(3):345-51. doi: 10.1507/endocrj.43.345. Endocr J. 1996. PMID: 8886631
-
Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.Am J Cardiovasc Drugs. 2005;5(6):379-87. doi: 10.2165/00129784-200505060-00005. Am J Cardiovasc Drugs. 2005. PMID: 16259526 Review.
-
Diet, exercise and weight loss and dyslipidaemia.Pathology. 2019 Feb;51(2):222-226. doi: 10.1016/j.pathol.2018.10.013. Epub 2018 Dec 7. Pathology. 2019. PMID: 30528924 Review.
Cited by
-
Systematic Review and Meta-Analysis of the Effects of Soy on Glucose Metabolism in Patients with Type 2 Diabetes.Rev Diabet Stud. 2019;15:60-70. doi: 10.1900/RDS.2019.15.60. Epub 2019 Oct 24. Rev Diabet Stud. 2019. PMID: 31648293 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical